Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Revenue (2016 - 2026)

Bio-Techne has reported Revenue over the past 17 years, most recently at $295.9 million for Q4 2025.

  • For Q4 2025, Revenue changed 0.39% year-over-year to $295.9 million; the TTM value through Dec 2025 reached $1.2 billion, up 1.64%, while the annual FY2025 figure was $1.2 billion, 5.23% up from the prior year.
  • Revenue for Q4 2025 was $295.9 million at Bio-Techne, up from $286.6 million in the prior quarter.
  • Over five years, Revenue peaked at $317.0 million in Q2 2025 and troughed at $2.0 million in Q3 2022.
  • A 5-year average of $271.9 million and a median of $288.8 million in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: crashed 99.22% in 2022 and later soared 13746.75% in 2023.
  • Year by year, Revenue stood at $269.3 million in 2021, then rose by 0.86% to $271.6 million in 2022, then grew by 0.37% to $272.6 million in 2023, then grew by 8.96% to $297.0 million in 2024, then fell by 0.39% to $295.9 million in 2025.
  • Business Quant data shows Revenue for TECH at $295.9 million in Q4 2025, $286.6 million in Q3 2025, and $317.0 million in Q2 2025.